Future work should investigate the effects of in vivo chronic intracochlear exposure to TNF-α and assessment of hearing and cochlear morphology at several sequential time points, in addition to further exploring etanercept's ability to protect against TNF-α-induced SNHL, and rescue hearing function post-exposure to TNF-α. Here, TNF is linked to sensorineural hearing loss disorder.